Drug allergy: A 2022 practice parameter update
David A. Khan(The University of Texas Southwestern Medical Center), Dana Wallace(Nova Southeastern University), Anne K. Ellis(Queen's University), Matthew Greenhawt(Asthma and Allergy Foundation of America), Julie Wang(Shanghai Jiao Tong University), Aleena Banerji(Massachusetts General Hospital), Roland Solensky(Oregon State University), Phil Lieberman(University of Tennessee Health Science Center), Kimberly G. Blumenthal(Massachusetts General Hospital), Matthew A. Rank(Mayo Clinic in Arizona), Caroline C. Horner(Washington University in St. Louis), David B.K. Golden(Johns Hopkins University), Derek K. Chu(Population Health Research Institute), Elizabeth J. Phillips(Murdoch University), Jonathan A. Bernstein(University of Cincinnati Medical Center), Andrew A. White(Scripps Health), John Oppenheimer(Rutgers, The State University of New Jersey), Marcus Shaker(Dartmouth–Hitchcock Medical Center), Dennis K. Ledford(University of South Florida), David R. Stukus(The Ohio State University)
Cited by 504
Related Papers
Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis
|The Lancet|2020|4.1k
Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report
|Journal of Allergy and Clinical Immunology|2010|2.3k
Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2019|1.7k